FERRARA, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.518
EU - Europa 1.394
AS - Asia 368
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 3.285
Nazione #
US - Stati Uniti d'America 1.510
UA - Ucraina 366
IE - Irlanda 302
SE - Svezia 281
HK - Hong Kong 98
IT - Italia 95
FI - Finlandia 92
SG - Singapore 91
DE - Germania 81
VN - Vietnam 81
RU - Federazione Russa 74
CN - Cina 57
GB - Regno Unito 30
JP - Giappone 19
CH - Svizzera 17
FR - Francia 14
TR - Turchia 11
AT - Austria 10
BE - Belgio 9
CA - Canada 8
CZ - Repubblica Ceca 5
NL - Olanda 5
UZ - Uzbekistan 5
PL - Polonia 4
EU - Europa 3
GR - Grecia 3
MD - Moldavia 3
IN - India 2
KR - Corea 2
LB - Libano 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
SO - Somalia 1
Totale 3.285
Città #
Chandler 343
Dublin 302
Jacksonville 162
San Mateo 154
Hong Kong 98
Medford 86
Princeton 86
Dong Ket 81
Ann Arbor 73
Des Moines 57
Wilmington 56
Singapore 53
Altamura 43
Lawrence 41
Perugia 38
Andover 37
Beijing 37
Norwalk 21
Saint Petersburg 21
Woodbridge 20
Boardman 19
Tokyo 19
Falls Church 11
Izmir 11
Moscow 11
Brussels 9
New York 9
Helsinki 8
Dearborn 7
San Paolo di Civitate 6
Ashburn 5
Edmonton 5
Lausanne 5
Los Angeles 5
Shanghai 5
Auburn Hills 4
Bromma 3
Cambridge 3
Chisinau 3
Frankfurt Am Main 3
San Diego 3
Chicago 2
Den Haag 2
Fabriano 2
Foligno 2
Groningen 2
Lansing 2
Pune 2
Redmond 2
Seoul 2
Southend 2
Stockholm 2
Tappahannock 2
Amsterdam 1
Arlington 1
Copenhagen 1
Corner Brook 1
Fairfield 1
Falkirk 1
Freiburg 1
Hanover 1
Hebei 1
Houston 1
Kiev 1
Montepulciano 1
Pavia 1
Richmond Hill 1
Stoke-on-Trent 1
Toronto 1
Totale 2.003
Nome #
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. 108
A decade of interferon-γ release assays: quest for the holy grail to diagnose latent infection with mycobacterium tuberculosis? 88
Basi genetiche della predisposizione alla tubercolosi (TB) ed alle micobatteriosi non tubercolari. 83
A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis. 83
Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension 75
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. 69
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children. 68
A method to quantify mycobacteria infection of cells from in vitro experiments 67
Il trattamento della tubercolosi. 65
Chronic empyema: importance of preventing complications in the management of pleural effusions 65
Long term Moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs. 64
Sarcoidosi: patogenesi 60
[Are targeted interventions needed in foreigner workers with latent tubercular infection? A study on anti-tubercular treatment compliance among health care workers] 60
Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. 54
Gender and other risk factors for multidrug-resistant (MDR) tuberculosis (TB) among migrants to Milan, Italy 53
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. 53
Combination fluticasone end salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children 52
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test 50
Alveolar macrophages produce CCL18 during early phases infection by M. tuberculosis 48
Trends and challenges in tuberculosis in a medium-sized southern European setting 47
Xpert MTB/RIF test for tuberculosis. 47
Macrolides for chronic asthma. 46
Interferon-gamma-release assays detect recent tuberculosis re-infection in elderly contacts. 46
Clinical and operational value of the XDR-TB definition. 45
Cough mechanical assistance in neuromuscular patients with respiratory failure: a retrospective evaluation 45
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 45
Combination fluticasone and salmeterol vs fixed dose combination budesonide and formoterol in adults and children 44
Clinical use of levofloxacin in the long term treatment of drug resistant tuberculosis 43
Corticosteroids for idiophatic pulmonary fibrosis. 42
Clinical use of Levofloxacin in the long term treatment of drug resistant tuberculosis. 42
Community acquired pneumonia in internal medicine: a one-year retrospective study based on pneumonia severity index. 42
C’è esigenza di interventi mirati nei lavoratori stranieri affettida infezione tubercolare latente? Uno studio sulla compliancealla terapia antitubercolare in operatori sanitari 41
Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. 41
Screening of immigrants in the UK for latent tuberculosis. 40
Use of an IGRA test for prescribing latent TB infection therapy in 374 immigrants applying to night shelters in Milan, Italy 40
Dossier Tubercolosi. La tubercolosi agli inizi del XXI secolo: diagnosi e terapia 40
Macrolides for chronic asthma. 39
Epidemiology and clinical managment of XDR-TB: a systematic review. 38
Micobatteriosi non tubercolari 38
Differences among multidrug-resistant tuberculosis patients in two metropolitan areas 38
Macrolides for chronic asthma 38
Corticosteroids for IPF: a systematic review 37
Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TB assay 36
Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. 35
Validation of the tuberculin skin test cut-off in BCG vaccinated individuals using the QuantiFERON-TB Gold 35
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. 33
Interferon-{gamma} release assays for the diagnosis of latent M. tuberculosis infection: A systematic review and meta-analysis. 33
Blood tests for diagnosis of tuberculosis - Authors' reply. 33
Tuberculosis in prisons: anatomy of global neglect. 33
Il trattamento della Tubercolosi 32
High risk of tuberculosis in health care workers in Romania. 32
Tuberculosis in prisons in sub-Saharan Africa--the need for improved health services, surveillance and control. 32
Molecular diagnosis of tuberculosis in a north Italian clinical setting: results of routine use of a commercial LCR-based test 32
Macrolides in the treatment of asthma and cystic fibrosis. 31
The best on infections: update from the 2010 ERS Congress. 31
New tools for a better diagnosis of latent tuberculosis infection 31
Macrolides for chronic asthma. 30
I nuovi test per la diagnosi di infezione tubercolare. 30
High risk of tuberculosis in health care workers in Romania 30
Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis 30
TB or not TB: update from the ERS Respiratory Infection Assembly 10. 30
Management of multidrug-resistant tuberculosis in Italy. 29
Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. 29
Performance of tests for latent tuberculosis in different groups of immunocompromised patients. 29
Mycobacterium tuberculosis induces CCL18 in human macrophages. 28
Management of MDR and rifampicin-resistant TB cases in Italy, 1995-1999 27
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 26
Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection. 25
Isoniazid preventive treatment: predictors of adverse events and treatment completion. 25
Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome 25
Extensively drug-resistant tuberculosis, Italy and Germany. 24
Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998-2000. 23
Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses? 22
Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group 22
Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan 22
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays 21
Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma 21
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence 20
T-Cell Therapy: Options for Infectious Diseases 20
Tuberculosis: Novel opportunities to control an old disease. 19
No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses. 19
Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry 19
Need for combined interventions and operational research to tackle tuberculous meningitis 19
Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis? 18
Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: The case of two Nordic countries 17
Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays 16
Totale 3.403
Categoria #
all - tutte 14.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.141


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020307 5 9 46 7 43 7 62 0 63 35 9 21
2020/2021743 4 56 34 59 214 52 45 1 88 34 62 94
2021/2022609 19 107 18 46 11 7 12 207 3 8 58 113
2022/20231.072 98 143 7 110 95 147 0 44 393 1 26 8
2023/2024362 21 57 22 10 4 3 59 3 68 5 53 57
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 3.403